Building on the success of our remote therapy model, this new service offers in-person psychological therapy sessions, designed to meet the growing demand for flexible, accessible and high-quality mental health support. Already commissioned by NHS Talking Therapies, the service is being piloted with strong early uptake and promising feedback.
While Xyla’s core offering remains unchanged, delivering high-quality, evidence-based therapy, the face-to-face model introduces:
This new model is a direct response to the evolving needs of NHS services and patients post-pandemic. While remote therapy has proven effective, many services are under pressure to offer in-person options due to digital exclusion, privacy concerns or clinical preference.
Xyla’s face to face model is uniquely positioned to meet this need, offering the flexibility and scalability of remote delivery, with the personal touch of in-person care.
Xyla is currently the only provider offering this hybrid model at scale. By leveraging Acacium Group’s national network of over 2,500 trained clinicians, we can mobilise services quickly and flexibly, tailoring delivery to each region’s needs.
This service is already live and available to NHS Talking Therapies across the UK. The model has been met with enthusiasm from both clinicians and commissioners.
If you’re an NHS Talking Therapies service looking to expand your face-to-face provision or simply want to explore how we can support your goals, please get in touch with our Senior Business Lead for Mental Health and Wellbeing, Robert.Taylor@xylaservices.com.
Have any questions about our services? Whether you’re wondering about how we can help your health goals, or assist your healthcare organisation, we’d love to hear from you.
Get in touchXyla is a trading name of ICS Operations Ltd (Registered No 4793945), Pulse Healthcare Limited (Registered No 3156103), Carehome Selection Limited (Registered No 3091598), Independent Clinical Services Limited (Registered No 4768329) and CHS Healthcare Software Limited (Registered No 11582111)